Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis, namely, ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for infectious lung diseases; pharmaceutical preparations for covid-19